C. D. Nicholson

1.6k total citations
35 papers, 1.3k citations indexed

About

C. D. Nicholson is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, C. D. Nicholson has authored 35 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 9 papers in Organic Chemistry and 8 papers in Pharmacology. Recurrent topics in C. D. Nicholson's work include Phosphodiesterase function and regulation (15 papers), Cholinesterase and Neurodegenerative Diseases (6 papers) and Synthesis and Catalytic Reactions (6 papers). C. D. Nicholson is often cited by papers focused on Phosphodiesterase function and regulation (15 papers), Cholinesterase and Neurodegenerative Diseases (6 papers) and Synthesis and Catalytic Reactions (6 papers). C. D. Nicholson collaborates with scholars based in United Kingdom, United States and Netherlands. C. D. Nicholson's co-authors include R. A. John Challiss, Mohammed Hasan Shahid, M. Shahid, Mohammed Shahid, Kenneth J. Broadley, J. de Boer, J. Zaagsma, J.H. Connick, Russell A. Wilke and R Schmitt and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Trends in Pharmacological Sciences and British Journal of Pharmacology.

In The Last Decade

C. D. Nicholson

35 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. D. Nicholson United Kingdom 16 899 449 267 242 236 35 1.3k
Richard J. Heaslip United States 17 823 0.9× 458 1.0× 188 0.7× 194 0.8× 191 0.8× 33 1.3k
Laura Rauser United States 10 552 0.6× 158 0.4× 433 1.6× 226 0.9× 110 0.5× 11 1.4k
Achim Feurer Germany 11 445 0.5× 503 1.1× 98 0.4× 43 0.2× 291 1.2× 14 1.1k
Ivan Milicic United States 19 554 0.6× 202 0.4× 151 0.6× 62 0.3× 164 0.7× 42 1.1k
Yvonne Vulliemoz United States 16 443 0.5× 258 0.6× 242 0.9× 73 0.3× 209 0.9× 52 1.0k
G. P�ch Austria 10 451 0.5× 324 0.7× 134 0.5× 101 0.4× 223 0.9× 15 861
R. Ouedraogo Belgium 16 456 0.5× 391 0.9× 101 0.4× 123 0.5× 285 1.2× 27 1.6k
C. van Breemen United States 22 966 1.1× 533 1.2× 357 1.3× 64 0.3× 388 1.6× 32 1.5k
Janet C. Wanstall Australia 29 1.0k 1.1× 1.1k 2.5× 448 1.7× 109 0.5× 591 2.5× 94 2.3k
Gerald O. Carrier United States 24 692 0.8× 827 1.8× 308 1.2× 92 0.4× 616 2.6× 44 1.5k

Countries citing papers authored by C. D. Nicholson

Since Specialization
Citations

This map shows the geographic impact of C. D. Nicholson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. D. Nicholson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. D. Nicholson more than expected).

Fields of papers citing papers by C. D. Nicholson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. D. Nicholson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. D. Nicholson. The network helps show where C. D. Nicholson may publish in the future.

Co-authorship network of co-authors of C. D. Nicholson

This figure shows the co-authorship network connecting the top 25 collaborators of C. D. Nicholson. A scholar is included among the top collaborators of C. D. Nicholson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. D. Nicholson. C. D. Nicholson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shahid, Mohammed & C. D. Nicholson. (2003). The Analysis and Assay of Cyclic Nucleotide Phosphodiesterase Isoenzyme Activity. Humana Press eBooks. 41. 129–150. 4 indexed citations
2.
Challiss, R. A. John, David Adams, Rajendra Mistry, & C. D. Nicholson. (1998). Modulation of spasmogen‐stimulated Ins(1,4,5)P3 generation and functional responses by selective inhibitors of types 3 and 4 phosphodiesterase in airways smooth muscle. British Journal of Pharmacology. 124(1). 47–54. 14 indexed citations
3.
Nicholson, C. D., M. Shahid, Jennifer E. Bruin, et al.. (1995). Characterization of ORG 20241, a combined phosphodiesterase IV/III cyclic nucleotide phosphodiesterase inhibitor for asthma.. Journal of Pharmacology and Experimental Therapeutics. 274(2). 678–687. 18 indexed citations
4.
Nicholson, C. D.. (1993). Cyclic Nucleotide Phosphodiesterase Isoenzymes and Asthma — Outstanding Issues. Birkhäuser Basel eBooks. 43. 3–12. 1 indexed citations
5.
Nicholson, C. D., et al.. (1992). ORG 20241, A CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE INHIBITOR FOR ASTHMA. Data Archiving and Networked Services (DANS). 2 indexed citations
6.
Connick, J.H., et al.. (1992). Multiple σ binding sites in guinea‐pig and rat brain membranes: G‐protein interactions. British Journal of Pharmacology. 107(3). 726–731. 32 indexed citations
7.
Boer, J. de, et al.. (1992). Human bronchial cyclic nucleotide phosphodiesterase isoenzymes: biochemical and pharmacological analysis using selective inhibitors. British Journal of Pharmacology. 106(4). 1028–1034. 112 indexed citations
8.
Nicholson, C. D., et al.. (1992). The Effect of Physical Training on Rat Calf Muscle, Oxygen Tension, Blood Flow, Metabolism and Function in an Animal Model of Chronic Occlusive Peripheral Vascular Disease. International Journal of Sports Medicine. 13(1). 60–64. 10 indexed citations
9.
Shahid, Mohammed, et al.. (1991). The presence of five cyclic nucleotide phosphodiesterase isoenzyme activities in bovine tracheal smooth muscle and the functional effects of selective inhibitors. British Journal of Pharmacology. 104(2). 471–477. 69 indexed citations
10.
Nicholson, C. D., R. A. John Challiss, & Mohammed Hasan Shahid. (1991). Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. Trends in Pharmacological Sciences. 12(1). 19–27. 398 indexed citations
11.
12.
Nicholson, C. D.. (1990). Pharmacology of nootropics and metabolically active compounds in relation to their use in dementia. Psychopharmacology. 101(2). 147–159. 105 indexed citations
13.
Shahid, M., Melba C. Wilson, C. D. Nicholson, & Richard Marshall. (1990). Species-dependent differences in the properties of particulate cyclic nucleotide phosphodiesterase from rat and rabbit ventricular myocardium. Journal of Pharmacy and Pharmacology. 42(4). 283–284. 19 indexed citations
14.
Challiss, R. A. John & C. D. Nicholson. (1990). Effects of selective phosphodiesterase inhibition on cyclic AMP hydrolysis in rat cerebral cortical slices. British Journal of Pharmacology. 99(1). 47–52. 28 indexed citations
15.
Nicholson, C. D., et al.. (1989). 8‐phenyltheophylline as an inhibitor of cyclic AMP hydrolysis by cyclic nucleotide phosphodiesterase. Journal of Autonomic Pharmacology. 9(3). 159–166. 13 indexed citations
16.
17.
Nicholson, C. D., et al.. (1989). The ability of denbufylline to inhibit cyclic nucleotide phosphodiesterase and its affinity for adenosine receptors and the adenosine re‐uptake site. British Journal of Pharmacology. 97(3). 889–897. 81 indexed citations
18.
Arch, J R, et al.. (1989). Tissue selective inhibition of cyclic nucleotide phosphodiesterase by denbufylline.. PubMed. 39(6). 665–7. 7 indexed citations
19.
Nicholson, C. D., et al.. (1979). The IN VIVO examination of the irreversible ?-adrenoceptor antagonist Ro 03-7894 on cardiac rate and contractility. Clinical and Experimental Pharmacology and Physiology. 6(6). 599–609. 7 indexed citations
20.
Broadley, Kenneth J. & C. D. Nicholson. (1978). Estimation of dissociation constants and relative efficacies of isoprenaline, orciprenaline and terbutaline in guinea-pig isolated atria by use of functional antagonism [proceedings].. PubMed. 64(3). 420P–421P. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard J. Heaslip Breakdown of academic impact, for papers by Laura Rauser Breakdown of academic impact, for papers by Achim Feurer Breakdown of academic impact, for papers by Ivan Milicic Breakdown of academic impact, for papers by Yvonne Vulliemoz Breakdown of academic impact, for papers by G. P�ch Breakdown of academic impact, for papers by R. Ouedraogo Breakdown of academic impact, for papers by C. van Breemen Breakdown of academic impact, for papers by Janet C. Wanstall Breakdown of academic impact, for papers by Gerald O. Carrier
Rankless by CCL
2026